Arcus Biosciences Inc (RCUS)

Exchange
NYSE
Symbol
RCUS
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and markets cancer therapies in the United States. The company is headquartered in Hayward, California.
Country
USA

Stock price

At close: December 20, 2024

  • Open
    15.11
  • High
    15.99
  • Low
    15.10
  • Close
    15.50
  • Volume
    1,846,680

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
—
Receivables turnover
29.25
Payables turnover
7.18
Working capital turnover
0.18
Days of inventory on hand (DOH)
—
Days of sales outstanding (DSO)
12.48
Number of days of payables
50.86
Fixed asset turnover
2.29
Total asset turnover
0.11
 Liquidity ratios
Current ratio
4.52
Quick ratio
4.15
Cash ratio
4.12
Cash conversion cycle
-38.38
 Solvency ratios
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
2.37
Interest coverage
-85.00
 Profitability ratios
Gross profit margin
-4.27%
Operating profit margin
-290.60%
Pretax margin
-257.26%
Net profit margin
-262.39%
Operating return on assets (Operating ROA)
-31.05%
Return on assets (ROA)
-28.04%
Return on total capital
-73.59%
Return on equity (ROE)
-66.45%